Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
OncoSil Medical Ltd ( (AU:OSL) ) just unveiled an announcement.
OncoSil Medical Ltd announced the appointment of Lelde Smits as a new director, effective January 15, 2025. This appointment is part of the company’s ongoing efforts to strengthen its leadership team, which is crucial for navigating the competitive landscape of the medical technology industry and enhancing its strategic direction.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical technology industry, focusing on developing and commercializing innovative medical products. The company primarily offers a targeted radioactive isotope treatment for pancreatic cancer, aiming to improve patient outcomes in oncology.
Average Trading Volume: 7,188,148
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$23.03M
See more insights into OSL stock on TipRanks’ Stock Analysis page.
